# Abivax SA (ABVX)

Eli Lilly jets are reportedly landing in Paris again, fueling intense buyout speculation for Abivax. Sanofi's CEO was abruptly ousted, adding to the M&A buzz.

### About Abivax SA
Abivax SA is a clinical-stage biotechnology company focused on developing novel small molecule drugs for inflammatory and fibrotic diseases.  
Abivax SA uses the ticker $ABVX for trading. Listed in the [Stocks](/list/stocks) category.

### Insights
- Abivax SA (ABVX) social dominance hit [------] which is 635% higher than it's daily average.
- Abivax SA (ABVX) market dominance near a 52-week high at [-------].
- Abivax SA (ABVX) social dominance is up 6475% from the previous year.
- Abivax SA (ABVX) engagements is up 50.36% from the previous week.
- Abivax SA (ABVX) mentions is up 25.87% from the previous week.
- Abivax SA (ABVX) posts created is up 198.31% from the previous week.
- Abivax SA Price hit a 52-Week high of $125.60 for the hour
- Abivax SA Price hit an all time of $125.60 for the hour

### Price: $125
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:abivax-sa/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/abivax-sa/time-series/close.tsv)  
The stock price is likely reacting positively to strong clinical trial results and ongoing M&A speculation, indicating investor confidence in the drug's potential and a possible acquisition. Recent social media posts echo this sentiment, with many discussing potential buyouts and the drug's efficacy.  

24-Hour: 0.59%
7-Day: 6.22%
30-Day: 6.74%

1-Year High: $145.30 on 2025-12-24  
1-Year Low: $6 on 2025-06-20  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:abivax-sa/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/abivax-sa/time-series/alt_rank.tsv)  
Abivax SA (ABVX) is currently AltRank #283 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [---] +250  
1-Year High: [---] on 2026-02-09  
1-Year Low: [--] on 2026-01-25  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:abivax-sa/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/abivax-sa/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] no change  
1-Year High: [--] on 2026-01-26  
1-Year Low: [--] on 2026-01-24  
  
  
### Engagements: [------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:abivax-sa/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/abivax-sa/time-series/interactions.tsv)  
Current Value: [------]  
Daily Average: [------]  
[--] Week: [-------] +50%  
[--] Month: [---------] -59%  
[--] Months: [----------] +232%  
[--] Year: [----------] +2,772%  
1-Year High: [---------] on 2025-07-23  
1-Year Low: [--] on 2025-05-10  

Engagements by network (24h):
Reddit: [--]
News: [--]
X: [------]
TikTok: [--]
YouTube: [--]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:abivax-sa/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/abivax-sa/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Week: [-----] +26%  
1-Year High: [-----] on 2025-07-24  
1-Year Low: [--] on 2025-05-10  

Mentions by network (24h):
Reddit: [--]
News: [--]
X: [---]
TikTok: [--]
YouTube: [--]

  
  
### Creators: [---] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:abivax-sa/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/abivax-sa/time-series/contributors_active.tsv)  
[---] unique social accounts have posts mentioning Abivax SA (ABVX) in the last [--] hours which is down 8.50% from [---] in the previous [--] hours
Daily Average: [---]  
[--] Week: [---] +8.90%  
1-Year High: [---] on 2025-07-24  
1-Year Low: [--] on 2025-05-10  

The most influential creators that mention Abivax SA in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@RNAiAnalyst](/creator/twitter/RNAiAnalyst)         | [--]    | [------]    | [--]     | [-----]       |
| [@seedy19tron](/creator/twitter/seedy19tron)         | [--]    | [------]    | [--]    | [-----]       |
| [@henners04](/creator/twitter/henners04)             | [--]    | [--]        | [--]     | [-----]       |
| [@wyv_123](/creator/twitter/wyv_123)                 | [--]    | [-----]     | [--]     | [-----]       |
| [@LaminarRed](/creator/twitter/LaminarRed)           | [--]    | [---]       | [--]     | [-----]       |
| [@davidmiedz](/creator/twitter/davidmiedz)           | [--]    | [-----]     | [--]     | [-----]       |
| [@Taintslapp12283](/creator/twitter/Taintslapp12283) | [--]    | [---]       | [--]    | [-----]       |
| [@henwil231](/creator/twitter/henwil231)             | [--]    | [---]       | [--]    | [-----]       |
| [@Duke0035](/creator/twitter/Duke0035)               | [--]    | [---]       | [--]     | [-----]       |
| [@bioadvo](/creator/twitter/bioadvo)                 | [--]   | [---]       | [--]    | [-----]       |

[View More](/list/creators/abivax-sa/100)
  
  
### Sentiment: 69%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:abivax-sa/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/abivax-sa/time-series/sentiment.tsv)  
Current Value: 69%  
Daily Average: 84%  
[--] Week: 53% -4%  
[--] Month: 62% -4%  
[--] Months: 62% -24%  
[--] Year: 62% -38%  
1-Year High: 100% on 2025-02-26  
1-Year Low: 50% on 2025-02-20  

Most Supportive Themes:
- Positive Trial Results: (60%) Abivax announced positive results from its Phase 2b clinical trial for obefazimod in ulcerative colitis patients. The drug demonstrated significant efficacy and a favorable safety profile.
- Regulatory Progress: (30%) The company is actively engaging with regulatory authorities, including the FDA and EMA, to advance obefazimod towards market approval. Discussions are ongoing regarding the next steps in the regulatory process.
  
Most Critical Themes:
- Competition in IBD Market: (7.5%) The inflammatory bowel disease (IBD) market is highly competitive, with several established and emerging therapies. Abivax's obefazimod will face significant competition from existing treatments and new entrants.
- Manufacturing Scale-Up Challenges: (2.5%) Scaling up manufacturing for a new pharmaceutical product can present challenges. Ensuring consistent quality and sufficient supply to meet potential market demand will be crucial for Abivax.
  
  
  
### Social Dominance: 0.042%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:abivax-sa/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/abivax-sa/time-series/social_dominance.tsv)  
Current Value: 0.042%  
Daily Average: 0.029%  
[--] Week: 0.132% +0.09%  
[--] Month: 0.21% +0.071%  
[--] Months: 0.21% +0.184%  
[--] Year: 0.21% +0.207%  
1-Year High: 0.21% on 2026-02-15  
1-Year Low: 0.0004% on 2025-05-10  
  
  
### Market Dominance: 0.011%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:abivax-sa/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/abivax-sa/time-series/market_dominance.tsv)  
Current Value: 0.011%  
Daily Average: 0%  
1-Year High: 0.011% on 2026-02-13  
1-Year Low: 0.01% on 2026-02-02  
  
  
### Market Cap: $9,905,428,110
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:abivax-sa/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/abivax-sa/time-series/market_cap.tsv)  
Current Value: $9,905,428,110  
Daily Average: $9,307,568,474  
[--] Week: $9,905,428,110 +6.60%  
[--] Month: $9,883,287,774 +7.90%  
1-Year High: $9,883,287,774 on 2026-02-13  
1-Year Low: $8,754,130,646 on 2026-02-05  

### Top Abivax SA Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"$ABVX Here we go. ➡ https://discord.com/invite/9nbJyyfT7e https://discord.com/invite/9nbJyyfT7e"  
[X Link](https://x.com/Dylanas19087/status/2022757697431519555) [@Dylanas19087](/creator/x/Dylanas19087) 2026-02-14T19:39Z [--] followers, [---] engagements


"@Taintslapp12283 I need that medieval dark ages $108 dollars ABVX. I want to go full power my NKTR winnings. $NKTR $ABVX"  
[X Link](https://x.com/Duke0035/status/2022681879678455839) [@Duke0035](/creator/x/Duke0035) 2026-02-14T14:38Z [---] followers, [---] engagements


"$ABVX ⚠👀 Guys Don't miss the next move in a few hours. 💸➡ https://discord.gg/7PCTB3DeVt https://discord.gg/7PCTB3DeVt"  
[X Link](https://x.com/OwenGrady195385/status/2022680904389529774) [@OwenGrady195385](/creator/x/OwenGrady195385) 2026-02-14T14:34Z [--] followers, [---] engagements


"@unemon1 @RGaridel18419 Likely that Morgan Stanley and Lilly folks are sharing the ride on some flights and that key Lilly people remain in Paris at this time. They can fly back with their MS friends after finalizing paperwork and making the deal announcement. Hopefully this is whats going on. $ABVX"  
[X Link](https://x.com/henwil231/status/2022672393097941054) [@henwil231](/creator/x/henwil231) 2026-02-14T14:00Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing